Investor Relations

Medizone International, Inc. Shareholder Information
Medizone International, Inc. trades under the ticker symbol “MZEI” Over-the-Counter and is fully reporting.

Additionally, Medizone International, Inc. is traded electronically OTCQB: MZEI.

Medizone International, Inc. (OTCBB: MZEI)
350 East Michigan Avenue – Suite 500
Kalamazoo, MI 49007

Telephone: (269) 202-5020


Medizone International, Inc. (MZEI) Traded:

Over the Counter Bulletin Board (OTCBB) MZEI

Electronically OTCQB: MZEI

The OTCBB is a regulated electronic trading service offered by the National Association of Securities Dealers (NASD) that shows real time quotes, last-sale prices and volume information for over-the-counter (OTC) equity securities. Companies listed on this exchange are required to file current financial statements with the Securities and Exchange Commission (SEC).

Common Stock Outstanding:

April 30, 2015, there were 351,334,068 shares of common stock issued and outstanding.

Transfer Agent:
American Stock Transfer & Trust
6201 15th Avenue
Brooklyn, NY 11219
Phone: 718.921.8200 (Contact Cindy Armenia at extension 6593)
Fax: 718.765.8711

Certified Public Accountant:
HJ & Associates, LLC
50 West Broadway, Suite 600
Salt Lake City, Utah 84101-2039


Investor Relations Contact:

John Pentony
[email protected]

Medizone Shareholder Alert

It has been brought to our attention that it has become increasingly difficult to deposit certificates evidencing free trading registered shares of OTCBB traded companies into retail brokerage accounts with many of the larger, well recognized brokerage firms.

Medizone and other key industry professionals, within the legal and financial industry, are taking a pro-active stance on this issue with the SEC and FINRA. In that regard, we have representitives taking part in an upcoming SEC meeting in Washington D.C. to address the current situation.

In this current regulatory environment, the large firms will act as Market Makers in OTCBB securities, such as MZEI, and will typically allow buying and selling of these same securities by retail account holders, but are making it difficult if not impossible for shareholders to deposit certificates evidencing fully registered shares into their client accounts.

In our opinion this is an unfair, illogical situation that clearly harms both issuers and shareholders and needs to be corrected.

Until FINRA and/or the SEC takes corrective action, we feel obligated to assist our shareholders in finding an effective and efficient solution for managing their accounts without undo hassle. Therefore, as a first step, we recommend that you contact your brokerage firm to discuss their policies on accepting shares of MZEI for deposit before delivering certificates to them.


If you are experiencing problems with a broker/dealer in connection with the sale or trading of securities on your behalf, you may also contact the Financial Industry Regulatory Authority (FINRA)’s Office of the Ombudsman toll free at (888) 700-0028 or by mail at FINRA Ombudsman, P.O. Box 9492, Gaithersburg, MD 20898-9492. Additional information is available on the FINRA website,


Medizone International, Inc. (OTCQB: MZEI)

350 East Michigan Avenue – Suite 500
Kalamazoo, MI 49007

Telephone: (269) 202-5020

Email: [email protected]

Media and Investor Relations:

John Pentony

Medizone International, Inc.

Telephone: (269) 202-5020

Email: [email protected]

Social Media